1. Home
  2. CXM vs CRVS Comparison

CXM vs CRVS Comparison

Compare CXM & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.50

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.86

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
CRVS
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
CXM
CRVS
Price
$5.50
$14.86
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$8.28
$30.17
AVG Volume (30 Days)
4.6M
1.2M
Earning Date
06-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.04
EPS
0.09
N/A
Revenue
$857,200,000.00
N/A
Revenue This Year
$2.52
N/A
Revenue Next Year
$4.94
N/A
P/E Ratio
$60.72
N/A
Revenue Growth
7.64
N/A
52 Week Low
$4.72
$3.38
52 Week High
$9.40
$26.95

Technical Indicators

Market Signals
Indicator
CXM
CRVS
Relative Strength Index (RSI) 52.59 45.36
Support Level $5.19 $13.81
Resistance Level $6.16 $19.21
Average True Range (ATR) 0.23 1.23
MACD 0.06 -0.08
Stochastic Oscillator 88.35 12.34

Price Performance

Historical Comparison
CXM
CRVS

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: